Heather Brandling-Bennett
Associate Professor
Department of Pediatrics
Clinical Adjunct, Division of Dermatology, Department of Medicine
MD, Seattle Children's Hospital

Faculty Information


Dr. Heather Brandling-Bennett is an Associate Professor in the Department of Pediatrics with an adjunct appointment in the Department of Medicine at the University of Washington School of Medicine. She graduated from Dartmouth College with a B.A. in Psychology and Biology, and then earned her M.D. from Harvard Medical School. She completed her internship in Pediatrics at Massachusetts General Hospital and residency in Dermatology at the Harvard Combined Dermatology Residency Training Program, followed by a fellowship in Pediatric Dermatology at Columbia University.

She is a member of the Society for Pediatric Dermatology (SPD), Pediatric Dermatology Research Alliance (PeDRA), Childhood Arthritis and Rheumatology Research Alliance (CARRA), Foundation for Ichthyosis & Related Skin Types (FIRST) Medical & Scientific Advisory Board, American Academy of Dermatology (AAD), and Washington State Dermatology Association (WSDA). She currently serves as the SPD Vice President of Workforce & Specialty Advocacy, co-chair of the PeDRA Best Practices in Pediatric Dermatology Task Force, and President of the WSDA.

Education & Training: 
Harvard Medical School
Boston MA
Internship in Pediatrics
Massachusetts General Hospital
Boston MA
Residency in Dermatology
Harvard Medical School
Boston MA
Fellowship in Pediatric Dermatology
Columbia University Medical Center
New York NY
Dartmouth College
Hanover NH
Seattle Top Docs (Seattle Met Magazine)
Seattle Top Docs (Seattle Magazine)
Seattle Top Docs (Seattle Magazine)
Seattle Top Docs (Seattle Met Magazine)
Mailing Address: 

To make an appointment with Dr. Brandling-Bennett, visit the Seattle Children's Hospital website.


Research & Clinical Interests
Research Interests: 
  • Dermatologic manifestations of autoimmune connective tissue disorders
  • Psoriasis
  • Complications from oncologic treatment
  • Pediatric Dermatology workforce
Clinical Interests: 
  • Dermatologic manifestations of autoimmune connective tissue disorders
  • Psoriasis
  • Disorders of keratinization
  • Vascular anomalies
  • Complications from oncologic treatment



Selected Publications

Do N, Ringold S, Sullivan E, Brandling-Bennett H. A retrospective study: Impact of consensus treatment plans on systemic therapy of pediatric morphea. Pediatr Dermatol 2020;37(2):278-283. PMID: 31967352

Do N, Ringold S, Brandling-Bennett H. Cutaneous polyarteritis nodosa in pediatric patients successfully treated with TNF-α inhibitor and methotrexate: Case series and literature review. Pediatr Dermatol 2019;36(6):932-935. PMID: 31576593

Arkin L, Buhr K, Brandling-Bennett HA, et al. Practice-based differences in pediatric discoid lupus erythematosus. Br J Dermatol 2019;181(4):805-10. PMID: 30768778

Kushner CJ, Tarazi M, Gaffney RG, Feng R, Ardalan K, Brandling-Bennett HA, et al.  Evaluation of the reliability and validity of the Cutaneous Lupus Erythematosus Disease Area and Severity Index (CLASI) in pediatric cutaneous lupus among pediatric dermatologists and rheumatologists. Br J Dermatol 2019;180(1):165-71. PMID: 30033560

Prindaville B, Horii KA, Siegfried EC, Brandling-Bennett H. Pediatric dermatology workforce in the United States. Pediatr Dermatol 2019;36(1):166-8. PMID: 30318628